The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.

Assembly Biosciences, Inc.’s ASMB share price has surged by 5.74%, which has investors questioning if this is right time to ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...